title: Safety and efficacy of oral potassium iodide in chromoblastomycosis.
authors.forename: S
authors.initials: S
authors.lastname: Narendranath
authors.forename: G K
authors.initials: GK
authors.lastname: Sudhakar
authors.forename: Mirabel R S M
authors.initials: MR
authors.lastname: Pai
authors.forename: Hema
authors.initials: H
authors.lastname: Kini
authors.forename: Jerome
authors.initials: J
authors.lastname: Pinto
authors.forename: Mirabel R S M
authors.initials: MR
authors.lastname: Pai
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use; D002862:Chromoblastomycosis / Q000188:drug therapy* / Q000473:pathology; D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D009281:Naphthalenes / Q000191:economics / Q000627:therapeutic use; D011193:Potassium Iodide / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D011193:Potassium Iodide; D000077291:Terbinafine